Drug Profile
Oncostatin M
Latest Information Update: 18 Jan 2008
Price :
$50
*
At a glance
- Originator Bristol-Myers Squibb
- Class Cytokines
- Mechanism of Action Immunostimulants
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer; Immunodeficiency disorders